Pancreatic Cancer Research

ResearcherGunma UniversityActive in the last 2 years

Takehiko Yokobori

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3284-4796; OpenAlex author ID A5003475519. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2017: 2 papers · 2018: 3 papers · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 12

  1. CD86-Positive Mature Tertiary Lymphoid Structures Are Associated With CD8+ T-Cell Infiltration and Favorable Clinical Outcomes in Pancreatic Ductal Adenocarcin… Co-author DOI 10.1002/ags3.70275↗
  2. Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Co-author DOI 10.1111/cas.16087↗
  3. High RRN3 expression is associated with malignant characteristics and poor prognosis in pancreatic cancer. Co-author DOI 10.1007/s10147-023-02342-w↗
  4. Editorial Comment on: MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscop… Co-author DOI 10.1245/s10434-020-09442-1↗
  5. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreati… Co-author DOI 10.1245/s10434-019-07708-x↗
  6. High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0226707↗
  7. Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts. Co-author DOI 10.1111/cas.13847↗
  8. Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00280-017-3477-4↗
  9. High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer. Co-author DOI 10.21873/anticanres.12307↗
  10. Investigation into metastatic processes and the therapeutic effects of gemcitabine on human pancreatic cancer using an orthotopic SUIT-2 pancreatic cancer mous… First author DOI 10.3892/ol.2017.7722↗
  11. Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression. Co-author DOI 10.18632/oncotarget.14703↗
  12. Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1. Co-author DOI 10.18632/oncotarget.22634↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kenichiro Araki · 9 shared papers, 2017–2026 · strength 1.03
  2. Ken Shirabe · 9 shared papers, 2017–2026 · strength 1.03
  3. Norihiro Ishii · 8 shared papers, 2017–2026 · strength 0.96
  4. Mariko Tsukagoshi · 8 shared papers, 2017–2026 · strength 0.96
  5. Akira Watanabe Watanabe · 8 shared papers, 2017–2024 · strength 0.75
  6. Takahiro Yamanaka · 7 shared papers, 2017–2024 · strength 0.68
  7. Takamichi Igarashi · 6 shared papers, 2017–2026 · strength 0.63
  8. Kei Hagiwara · 5 shared papers, 2018–2024 · strength 0.56
  9. Norifumi Harimoto · 5 shared papers, 2018–2024 · strength 0.56
  10. Hiroyuki Kuwano · 5 shared papers, 2017–2019 · strength 0.33
  11. Takaomi Seki · 1 shared paper, 2026 · strength 0.28
  12. Atsushi Masamune · 2 shared papers, 2019–2024 · strength 0.26
  13. Bolag Altan · 3 shared papers, 2017–2018 · strength 0.19
  14. Kiyoaki Ito · 1 shared paper, 2024 · strength 0.18
  15. Chingunjav Batbayar · 1 shared paper, 2023 · strength 0.15
  16. Takayuki Asao · 1 shared paper, 2018 · strength 0.09
  17. Shinji Hagiwara · 1 shared paper, 2018 · strength 0.09
  18. Tamami Higuchi · 1 shared paper, 2018 · strength 0.09
  19. Erica Yada · 1 shared paper, 2020 · strength 0.08
  20. Satoshi Wada · 1 shared paper, 2020 · strength 0.08
  21. Tetsuro Sasada · 1 shared paper, 2020 · strength 0.08
  22. Yutaro Kubota · 1 shared paper, 2020 · strength 0.08
  23. Koji Tamada · 1 shared paper, 2020 · strength 0.08
  24. Ryotaro Ohkuma · 1 shared paper, 2020 · strength 0.08
  25. Tomoko Norose · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.